No longer in business, Cambridge Scientific, Inc. was a biomedical research and development company dedicated to the development of biopolymer-based devices for medical applications, with a particular focus on orthopedics. CSI utilized its relationships with university and industrial collaborators to conduct laboratory work, realize development activity, and consult on new product development. This approach allowed the company to supplement in-house technical expertise and administrative abilities with the world-class facilities offered by top universities and special testing facilities. CSI was recently granted FDA 510(k) clearance for its WISORB(tm) Malleolar Screw. Additionally, its bioabsorbable DONTEX(tm) bone graft substitute is currently in preclinical trials, and the company is ready to begin preclinical development with its bioabsorbable WISORB(tm) Spinal Fusion System for lumbar fusion.
